Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Mar 23.
Published in final edited form as: Tetrahedron Lett. 2016 Mar 23;57(12):1335–1337. doi: 10.1016/j.tetlet.2016.02.041

Stereocontrolled regeneration of olefins from epoxides

Veronica S Wills a, Xiang Zhou a, Cheryl Allen b, Sarah A Holstein b, David F Wiemer a,
PMCID: PMC4778745  NIHMSID: NIHMS762265  PMID: 26955189

Abstract

Through treatment with NaI and trifluoroacetic anhydride, which presumably forms trifluoroacetyl iodide in situ, epoxides can be converted to olefins. This reaction now has been shown to tolerate remote olefins without loss of their individual stereochemistry. A reaction sequence involving regiospecific epoxidation of an isoprenoid alcohol, conversion of the alcohol to an azide, and cycloaddition with an acetylene, followed by conversion of the epoxide back to the original olefin, has allowed stereocontrolled preparation of triazole bisphosphonates with a farnesyl or a geranylgeranyl substituent. This strategy may be applicable selective protection of an alkene in other polyolefins, including substrates for metathesis reactions.

Keywords: epoxide, deoxygenation, phosphonate, triazole

Graphical Abstract

graphic file with name nihms-762265-f0001.jpg


The carbon-carbon double bond of an olefin is not often described as the central functional group of organic synthesis, but perhaps it should be. On the one hand, it is found within an enormous number of natural products including the majority of terpenoids and steroids. On the other hand, it can be transformed into alcohols, amines, diols, and epoxides among other functional groups, and participate in reactions including oxidative cleavage, the Diels-Alder reaction, and the Heck reaction. The tremendous interest in olefin metathesis further amplifies its value. An assortment of protecting groups has been developed for various other functional groups, and epoxides can be a convenient protecting group for olefins. But in order for this protecting group to be practical, it is important that it be removable in good yield and with a predictable impact on the original olefin stereochemistry.

Our interest in the utilization of epoxides as an olefin protecting group stems from work we have done with click chemistry1,2,3 to make isoprenoid triazole bisphosphonates as potential inhibitors of downstream enzymes in the isoprenoid biosynthetic pathway, especially geranylgeranyl diphosphate synthase (GGDPS).4,5 For example, the geranyl (1) and neryl (2) triazoles can be prepared easily by a click reaction of an acetylenic bisphosphonate6 with an isoprenoid azide. However, whether the geranyl or neryl azide is employed, the resulting triazole is obtained as a ~2:1 mixture of olefin isomers due to an allylic azide rearrangement that equilibrates the olefin stereochemistry.7 After bioactivity was observed in a mixture of geranyl and neryl isomers,1 it became important to avoid the allylic azide rearrangement and prepare each individually. We recently reported the activity of bisphosphonates 1 and 2 as single olefin isomers and, perhaps surprisingly, the neryl isomer 2 was the more potent inhibitor of GGDPS.2 The individual olefins were prepared via their corresponding epoxides, and those epoxides were not active in our bioassays. An attempt to reduce the epoxide to the olefin after the click reaction using Caputo's conditions of TMSCl and NaI8 only returned starting material. However, deoxygenation to furnish compounds 1 and 2 was achieved upon treatment with trifluoroacetic anhydride (TFAA) and NaI under conditions first reported by Sonnet,9 which is thought to form trifluoroacetyl iodide in situ. In this case it was important to note that the olefin was regenerated with stereochemistry present in the original alcohol. However, because the terminal olefin in compounds 1 and 2 does not have stereochemistry, it was unclear whether this strategy could be used to prepare individual isomers of triazoles derived from longer isoprenoids. We now report that this strategy has been applied successfully to preparation of farnesyl and geranylgeranyl derivatives, and that the remote olefins are tolerated by the necessary reaction conditions.

To explore the viability of this strategy with larger isoprenoids, initially the C15 derivatives were prepared from commercially available (2E, 6E)–farnesol (3, Scheme 1). The reaction sequence begins with treatment of the alcohol 3 with VO(C5H7O2)2 and TBHP to afford epoxyfarnesol (4, Scheme 1). The resulting primary alcohol then was converted to bromide 510 through a mesylate intermediate.

Scheme 1.

Scheme 1

Synthesis of racemic epoxide 5.

As outlined in Scheme 2, preparation of the C20 azide required a somewhat longer sequence because pure (2E, 6E, 10E)–geranylgeraniol is not commercially available. Therefore alcohol 8 was prepared from farnesyl acetone (6).11 A Horner-Wadsworth-Emmons (HWE) condensation of triethyl phosphonoacetate and farnesyl acetone (6) provided ester 7 as a mixture of olefin isomers (approximately 10:1 E : Z). Because the E- and Z-isomers were not readily separable by column chromatography at this stage, they were carried forward as a mixture. After the esters were reduced to alcohols by treatment with LiAlH4, the individual isomers were obtained by column chromatography to afford pure (2E, 6E, 10E)–geranylgeraniol (8) in 61% yield.11 Regioselective formation of epoxygeranylgeraniol (9) was accomplished by treatment of alcohol 8 with vanadyl acetylacetonate and TBHP.12,13 The resulting epoxide then was allowed to react with MsCl, followed by LiBr to afford the primary bromide 10.

Scheme 2.

Scheme 2

Synthesis of racemic epoxide 10.

In anticipation of a click reaction with the acetylene bisphosphonate 11,6 the bromide 5 was allowed to react with NaN3. Out of concern for the stability of the resulting azide (12), once this intermediate was formed it was subjected to standard click reaction conditions with only minimal purification. Reaction of the primary azide 12 and acetylene bisphosphonate 11 under standard click reaction conditions6 gave the desired triazole bisphosphonate 13. The critical deoxygenation was accomplished through formation of trifluoroacetyl iodide in situ from NaI and TFAA, and the olefin was regenerated to provide the farnesyl triazole bisphosphonate 14 as a single isomer. The geometry of the olefin was confirmed by observation of the diagnostic signal at 39.6 ppm in the 13C NMR spectrum corresponding to the methylene adjacent to the newly formed olefin. This is comparable to the resonance reported for the corresponding carbon in (2E, 6E)–farnesol (39.8 ppm) and certainly distinct from the signal for the same carbon in (2Z, 6E)–farnesol (32.7 ppm).11,14 Furthermore there was no detectable scrambling of the central olefin stereochemistry, as determined by the presence of a second resonance at 39.8 ppm, and comparison of the 13C NMR resonances with those of other linear isoprenoids.11,14 The target farnesyl triazole bisphosphonate sodium salt 15 finally was obtained by hydrolysis of bisphosphonate ester 14 under standard conditions.15

In a parallel fashion, bromide 10 was treated with NaN3 to form the primary azide 16, which then was subjected to click reaction conditions (CuSO4, sodium ascorbate, and acetylene bisphosphonate 116) to provide the triazole bisphosphonate 17. The next step was to reduce the epoxide, and stereospecific regeneration of the olefin and was accomplished by treatment of the epoxide with NaI and TFAA under Sonnet's conditions9 to provide triazole bisphosphonate 18 as a single isomer. The 13C NMR spectrum confirmed that that the regenerated olefin was the E-isomer. Specifically, the resonance at 39.7 ppm could be attributed to the methylene adjacent to the more substituted carbon of the newly formed olefin, and was compared to the corresponding carbon in (2E, 6E, 10E)–geranylgeraniol (39.8 ppm). This signal is much different from the methylene carbon of the (2Z, 6E, 10E)-isomer, which would have a resonance at 32.1 ppm for the same carbon.11,16 Once again there was no apparent scrambling of the two central olefins’ stereochemistry based on the 13C NMR spectrum. For compound 18 a total of three resonances were observed ~39 ppm, as expected for the all-trans isomer based on literature data for other linear isoprenoids.11,14 Furthermore, the spectrum of epoxide 17 showed just two resonances in this region. Finally, the tetraethyl ester of bisphosphonate 18 was hydrolyzed under standard conditions by treatment with TMSBr and collidine followed by NaOH15 to afford the corresponding sodium salt 19.

Triazole bisphosphonates 15 and 19 have been tested for their activity as inhibitors of several enzymes in the isoprenoid biosynthetic pathway. These enzyme assay results, as well as those from an assay for cellular activity, are summarized in Table 1 below. In enzyme assays, these two compounds showed only very modest activity as GGDPS inhibitors and they were not as active as the C10 isoprenoid triazole bisphosphonates we already have reported.2 Compounds 15 and 19 showed no activity in the cell assays (Table 1 and SI).

Table 1.

Enzyme and cellular assay data.

Compound GGDPS IC50 (μM) FDPS IC50 (μM) GGTase II IC50 (μM) Cellular activity at 100 μM*
15 40 58 1000 None
19 123 103 >1000 None
*

Cellular activity was assessed by immunoblot analysis for unmodified Rap1a and Rab6 (SI) as well as intracellular light chain levels (data not shown).

In conclusion, the new farnesyl and geranylgeranyl triazole bisphosphonates, 15 and 19 respectively, have been synthesized as single olefin isomers via click chemistry. In order to avoid an allylic azide rearrangement that results in olefin isomerization, the C-2 olefin was protected as an epoxide and then reduced to the olefin after the click reaction. The deoxygenation proceeded smoothly upon treatment with NaI and TFAA, and the olefin regenerated after removal of the epoxide was a single isomer of the same geometry present in the original allylic alcohol. While compounds 15 and 19 did not have potent biological activity, these syntheses not only broaden the substrate scope of the original report9 on deoxygenation beyond epoxides with no additional functionality, but they also illustrate the stability of remote olefins to these reaction conditions. The insight gained from this work can be applied in the synthesis of similar compounds as well as in other uses of an epoxide as an olefin protecting group. For example, synthetic strategies including olefin metathesis have become common in organic chemistry, and recent examples conducted in the presence of a remote epoxide can be found based on cross metathesis with electron deficient olefins,17 ring-closing olefin metathesis,18,19 and ene-yne metathesis.20 Given the ability to regenerate an olefin from an epoxide in the presence of additional olefins while preserving their stereochemistry, one can easily imagine application through sequences involving epoxidation, metathesis, and conversion of the epoxide back to an olefin.

Supplementary Material

Figure 1.

Figure 1

Isoprenoid triazole bisphosphonates that inhibit GGDPS.

Scheme 3.

Scheme 3

Synthesis of triazole bisphosphonates.

Acknowledgments

We thank the UI Graduate College for a Dean's Graduate Fellowship and an AGEP Fellowship (VSW), and the Center for Biocatalysis and Bioprocessing for a fellowship (VSW) through the Predoctoral Training Program in Biotechnology (T32 GM008365). Financial support from the NIH (R01CA-172070), the American Society of Hematology (a Scholar Award to SAH), and the Roy J. Carver Charitable Trust through its Research Program of Excellence (to DFW), is gratefully acknowledged.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Supplementary data

Experimental procedures and/or spectral data for compounds 10 and 1219 are available as well as additional bioassay data. Supplementary data associated with this article can be found in the online version at doi:

References and Notes

  • 1.Zhou X, Hartman SV, Born EJ, Smits JP, Holstein SA, Wiemer DF. Bioorg. Med. Chem. Lett. 2013;23:764. doi: 10.1016/j.bmcl.2012.11.089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zhou X, Ferree SD, Wills VS, Born EJ, Tong H, Wiemer DF, Holstein SA. Bioorg. Med. Chem. 2014;22:2791. doi: 10.1016/j.bmc.2014.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wills VS, Allen C, Holstein SA, Wiemer DF. ACS Med. Chem. Lett. 2015 doi: 10.1021/acsmedchemlett.5b00334. Ahead of Print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wiemer AJ, Yu JS, Shull LW, Barney RJ, Wasko BM, Lamb KM, Hohl RJ, Wiemer DF. Bioorg. Med. Chem. 2008;16:3652. doi: 10.1016/j.bmc.2008.02.016. [DOI] [PubMed] [Google Scholar]
  • 5.Wiemer AJ, Yu JS, Lamb KM, Hohl RJ, Wiemer DF. Bioorg. Med. Chem. 2008;16:390. doi: 10.1016/j.bmc.2007.09.029. [DOI] [PubMed] [Google Scholar]
  • 6.Skarpos H, Osipov SN, Vorob'eva DV, Odinets IL, Lork E, Roschenthaler GV. Org. Biomol. Chem. 2007;5:2361. doi: 10.1039/b705510b. [DOI] [PubMed] [Google Scholar]
  • 7.Feldman AK, Colasson B, Sharpless KB, Fokin VV. J. Am. Chem. Soc. 2005;127:13444. doi: 10.1021/ja050622q. [DOI] [PubMed] [Google Scholar]
  • 8.Caputo R, Mangoni L, Neri O, Palumbo G. Tetrahedron Lett. 1981;22:3551. [Google Scholar]
  • 9.Sonnet PE. J. Org. Chem. 1978;43:1841. [Google Scholar]
  • 10.Marshall JA, Hann RK. J. Org. Chem. 2008;73:6753. doi: 10.1021/jo801188w. [DOI] [PubMed] [Google Scholar]
  • 11.Yu JS, Kleckley TS, Wiemer DF. Org. Lett. 2005;7:4803. doi: 10.1021/ol0513239. [DOI] [PubMed] [Google Scholar]
  • 12.Sharpless KB, Michaelson RC. J. Am. Chem. Soc. 1973;95:6136. [Google Scholar]
  • 13.Lempers HEB, Ripollès i Garcia A, Sheldon RA. J. Org. Chem. 1998;63:1408. [Google Scholar]
  • 14.Bohlmann F, Zeisberg R, Klein E. Organic Magnetic Resonance. 1975;7:426. [Google Scholar]
  • 15.McKenna CE, Higa MT, Cheung NH, McKenna MC. Tetrahedron Lett. 1977;18:155. [Google Scholar]
  • 16.Wills VS. Ph. D. University of Iowa; 2015. [Google Scholar]
  • 17.Abderrezak MK, Sichova K, Dominguez-Boblett N, Dupe A, Kabouche Z, Bruneau C, Fischmeister C. Beilstein J. Org. Chem. 2015;11:1876. doi: 10.3762/bjoc.11.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kanoh N, Kawamata A, Itagaki T, Miyazaki Y, Yahata K, Kwon E, Iwabuchi Y. Org. Lett. 2014;16:5216. doi: 10.1021/ol502633j. [DOI] [PubMed] [Google Scholar]
  • 19.Lv LY, Shen BJ, Li ZP. Angew. Chem. Int. Ed. 2014;53:4164. doi: 10.1002/anie.201400326. [DOI] [PubMed] [Google Scholar]
  • 20.Jecs E, Diver ST. Tetrahedron Lett. 2014;55:4933. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

RESOURCES